Nebius, Stock

Nebius Stock: A $27 Billion Buildout, a Trimmed Sales Outlook, and the 2027 Handover That Now Does the Grading

Published on 11/17/2026 at 16:31 | Editorial boerse-global.de
Nebius shares gain 2.2% to €99.62 as two analysts cut targets. Q3 revenue jumped 571%, but data-center delays push 2026 revenue to low end of guidance.
Nebius Stock: A $27 Billion Buildout, a Trimmed Sales Outlook, and the 2027 Handover That Now Does the Grading Illustration mit AI erstellt.

Nebius shares were up 2.2% on Tuesday, trading at €99.62, as battered technology names steadied themselves ahead of Nvidia's earnings. The gain puts a little distance between the stock and a week in which two analysts cut their price targets while both kept their buy-or-hold convictions intact — a split that says as much about the calendar as it does about the company.

The debate investors are actually having is not whether demand exists. It is whether that demand can be converted into revenue on schedule. Nebius reported third-quarter 2026 revenue of $980.8 million on Friday, a jump of 571% year over year, alongside adjusted EBITDA of $465.8 million. The continued business posted a net loss of $37.5 million. Against any argument about delays, that is already a substantially grown operation.

What clouds the near-term picture is timing. Some of the data-center capacity Nebius had expected from third-party providers this year is now slipping into the first half of 2027, the company said. As a result, full-year 2026 revenue is expected to land at the low end of the $3.0 billion to $3.4 billion range. For 2027, Nebius for the first time dangled a revenue figure of $12 billion to $13 billion.

The capital plan has moved in the opposite direction. Nebius raised its investment budget to roughly $27 billion — a short-term revenue outlook that got more cautious sitting alongside a planned outlay that got larger. That spending total is not a scorecard in itself; it has to be justified by usable capacity and the business that capacity generates.

Should investors sell immediately? Or is it worth buying Nebius?

Analysts have been recalibrating accordingly. Citi lowered its price target on Monday to $215 from $265, keeping its buy rating. D.A. Davidson cut its target on Friday to $125 from $250, with analyst Gil Luria maintaining a neutral stance. The pattern is instructive: a constructive longer-term view does not preclude a lower valuation, and an unchanged rating does nothing to erase operational slippage.

The useful distinction for shareholders is between a deferral and a permanent loss. A shift in timing is not the same as expected business vanishing — and it is not proof that the later revenue is locked in either. The bullish case rests on the delayed capacity actually arriving and then producing sales, which would make the whole episode a scheduling problem rather than a demand problem. The starting point for that view is the growth already booked: the 571% quarterly surge shows the thesis does not lean entirely on future business. What it does not show is that the next phase of the buildout will go as smoothly.

The bearish case is a second slip. Should expected availability be pushed out again, the hoped-for revenue contribution drifts further into the future while the enlarged investment plan sets the bar for execution — more money committed, waiting longer for its commercial payoff. The real risk is not another guidance trim so much as a widening gap between what is being built and what is actually generating revenue.

Nebius at a turning point? This analysis reveals what investors need to know now.

That makes 2027 the date that matters. Progress reports on bringing the delayed capacity online may well carry more weight than further target revisions. The growth already delivered stands as evidence of the business to date; the success of the coming expansion is something Nebius still has to prove, through capacity that is available and revenue that follows from it.

Ad

Nebius Stock: New Analysis - 17 November

Fresh Nebius information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nebius analysis...

Disclaimer...
en | NL0009805522 | NEBIUS | boerse | 70527619 |